Massive Bio
Still Running· since Sep 1, 2026
- 29
- days running
- 0
- relaunches
Ad copy
Diagnosed with HER2-mutated non-small cell lung cancer? A clinical trial is enrolling patients with HER2 (ERBB2) activating mutations who haven't received systemic treatment for advanced disease. An oral targeted therapy alternative to chemo-immunotherapy may be available
HER2-Mutated NSCLC?
HER2-mutated NSCLC trial enrolling. Chemo-free oral alternative. See if you qualify today.
LEARN MORE🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
